Regarding sentinel lymph node biopsy using CEUS, Omoto et al. conducted a basic study using a 25% albumin contrast agent in 2002 [137], followed by the first report of identifying sentinel lymph nodes in breast cancer patients in 2006 [138]. Here, ALB is linked to breast carcinoma.